GRK2 Antikörper (AA 1-689)
-
- Target Alle GRK2 (ADRBK1) Antikörper anzeigen
- GRK2 (ADRBK1) (Adrenergic, Beta, Receptor Kinase 1 (ADRBK1))
-
Bindungsspezifität
- AA 1-689
-
Reaktivität
- Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser GRK2 Antikörper ist unkonjugiert
-
Applikation
- ELISA
- Kreuzreaktivität
- Maus
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Mouse Beta-adrenergic receptor kinase 1 protein (1-689AA)
- Isotyp
- IgG
- Top Product
- Discover our top product ADRBK1 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- GRK2 (ADRBK1) (Adrenergic, Beta, Receptor Kinase 1 (ADRBK1))
- Andere Bezeichnung
- Grk2 (ADRBK1 Produkte)
- Synonyme
- Adrbk-1 antikoerper, Bark-1 antikoerper, GRK2 antikoerper, betaARK1 antikoerper, BARK1 antikoerper, BETA-ARK1 antikoerper, GRK-2 antikoerper, Grk2 antikoerper, beta-adrenergic receptor kinase 1 antikoerper, G protein-coupled receptor kinase 2 antikoerper, Tsp_00497 antikoerper, grk2 antikoerper, Grk2 antikoerper, GRK2 antikoerper
- Hintergrund
-
Background: Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors, probably inducing a desensitization of them.
Aliases: Grk2 antibody, Adrbk1Beta-adrenergic receptor kinase 1 antibody, Beta-ARK-1 antibody, EC 2.7.11.15 antibody, G-protein-coupled receptor kinase 2 antibody
- UniProt
- Q99MK8
- Pathways
- EGFR Signaling Pathway, Neurotrophin Signalübertragung, Regulation of G-Protein Coupled Receptor Protein Signaling, CXCR4-mediated Signaling Events, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling
-